Seattle Genetics Inc (NASDAQ:SGEN)

37.14
Delayed Data
As of Apr 24
 -0.36 / -0.96%
Today’s Change
30.05
Today|||52-Week Range
44.95
+15.59%
Year-to-Date

Today’s Trading

Previous close37.50
Today’s open37.55
Day’s range37.12 - 38.29
Volume794,243
Average volume (3 months)1,102,604
Market cap$4.7B
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-14.72%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book22.05

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC+0.97+3.15%
GRFSGrifols SA+0.32+0.95%
RCPTReceptos Inc-1.25-0.73%
ACADACADIA Pharmaceutica...-0.54-1.39%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 1, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers